Elon Musk is well-known for many things: Tesla, SpaceX, Neuralink, and his Boring Company, among others. He's also known for sharing his opinions, however blunt they sometimes might be, online for all to see — Twitter being his main platform where to voice his thoughts.
On Monday, The New York Times' Kara Swisher interviewed Musk on basically everything, as well as his thoughts on taking the COVID-19 vaccine. To put it explicitly, he won't be taking it, nor will his family.
We're all entitled to our own opinions
In his interview with Swisher, Musk quite quickly said "Let's just move on," when she persevered to ask the tech mogul questions around his thoughts on COVID-19.
This isn't the first time Musk tells an interviewer to "move on" in regards to discussing the coronavirus pandemic. In fact, he's been rather upfront about what he thinks about the reaction to the pandemic since the get-go, famously stating on Twitter that the panic surrounding it is "dumb."
He did say, however, in his recent interview with Swisher, that he would not be getting the COVID-19 vaccine once it's ready, as he's "not at risk." She pushed him to explain why, and he simply stated that neither he nor his kids were at risk of COVID-19.
Swisher wouldn't quite let the issue go, and mentioned that lockdowns were put in place to "save humanity," to which Musk simply replied, "everybody dies." He's not wrong, we'll give him that, and even Swisher agreed. Perhaps its a truth no one wants to hear, but it's a tough pill to swallow.
Unfortunately, the whole thing has "diminished my faith in humanity," explained Musk.
The tech giant did state that if people are at risk they should stay home, but that those who are fit, young, and healthy should keep operating in their day to day lives normally.
Swisher couldn't get much more out of Musk on the subject as he threatened to end the podcast interview if she kept pushing.
It has to be noted, though, as Musk himself pointed out during the interview, that Tesla has been making vaccine machines called CureVac, and that his team has been spending "quite a lot of time with the Harvard epidemiology team doing antibody tests." Fair play, Musk, fair play.